glp-1 drugs uk New 'unusual' side effect of weight-loss becoming more common, research suggests what are examples of glp

doi: 10.1111/dom.14944

This translated into seven fewer new substance use disorder diagnoses per 1,000 GLP-1 users

This observation aligns with previous work showing that pharmacological inhibition or genetic ablation of NMDA receptors in agouti-related-protein (AgRP)-expressing neurons alters synaptic adaptation to fasting 39,40

Affordable tirzepatide options exist through compounding pharmacies, but regulatory changes have tightened access to compounded tirzepatide significantly

Moreover, small-molecule GLP-1RAs offer a solution to the bioavailability limitations faced by oral peptide-based agents, which often depend on absorption enhancers (e.g., SNAC) and strict fasting protocols [74]

HRT decisions around surgery are typically made independently based on clot risk and the type of procedure